139 related articles for article (PubMed ID: 9457187)
1. Superparamagnetic iron oxide particles (SH U 555 A): evaluation of efficacy in three doses for hepatic MR imaging.
Shamsi K; Balzer T; Saini S; Ros PR; Nelson RC; Carter EC; Tollerfield S; Niendorf HP
Radiology; 1998 Feb; 206(2):365-71. PubMed ID: 9457187
[TBL] [Abstract][Full Text] [Related]
2. Clinical results with Resovist: a phase 2 clinical trial.
Reimer P; Rummeny EJ; Daldrup HE; Balzer T; Tombach B; Berns T; Peters PE
Radiology; 1995 May; 195(2):489-96. PubMed ID: 7724772
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic efficacy and safety of MRI of the liver with superparamagnetic iron oxide particles (SH U 555 A).
Kehagias DT; Gouliamos AD; Smyrniotis V; Vlahos LJ
J Magn Reson Imaging; 2001 Nov; 14(5):595-601. PubMed ID: 11747012
[TBL] [Abstract][Full Text] [Related]
4. Hepatic MR imaging with ferumoxides: multicenter study of safety and effectiveness of direct injection protocol.
Bluemke DA; Weber TM; Rubin D; de Lange EE; Semelka R; Redvanly RD; Chezmar J; Outwater E; Carlos R; Saini S; Holland GA; Mammone JF; Brown JJ; Milestone B; Javitt MC; Jacobs P
Radiology; 2003 Aug; 228(2):457-64. PubMed ID: 12893904
[TBL] [Abstract][Full Text] [Related]
5. Multicentre dose-ranging study on the efficacy of USPIO ferumoxtran-10 for liver MR imaging.
Saini S; Sharma R; Baron RL; Turner DA; Ros PR; Hahn PF; Small WC; Delange EE; Stillman AE; Edelman RR; Runge VM; Outwater EK
Clin Radiol; 2000 Sep; 55(9):690-5. PubMed ID: 10988047
[TBL] [Abstract][Full Text] [Related]
6. [Dose investigation of superparamagnetic iron oxide (SPIO) SH U 555 A in liver MR imaging].
Hirohashi S; Ichikawa T; Tanimoto A; Isobe Y; Hachiya J; Saito K; Isoda H; Nishimura H; Kuwatsuru R; Gokan T; Murakami T; Nakano S; Seriu T
Nihon Igaku Hoshasen Gakkai Zasshi; 2003 Nov; 63(9):539-50. PubMed ID: 14699862
[TBL] [Abstract][Full Text] [Related]
7. MR imaging of the liver with Resovist: safety, efficacy, and pharmacodynamic properties.
Kopp AF; Laniado M; Dammann F; Stern W; Grönewäller E; Balzer T; Schimpfky C; Claussen CD
Radiology; 1997 Sep; 204(3):749-56. PubMed ID: 9280254
[TBL] [Abstract][Full Text] [Related]
8. Superparamagnetic iron oxide hepatic MR imaging: efficacy and safety using conventional and fast spin-echo pulse sequences.
Schwartz LH; Seltzer SE; Tempany CM; Silverman SG; Piwnica-Worms DR; Adams DF; Herman L; Herman LA; Hooshmand R
J Magn Reson Imaging; 1995; 5(5):566-70. PubMed ID: 8574043
[TBL] [Abstract][Full Text] [Related]
9. Ring enhancement in ultrasmall superparamagnetic iron oxide MR imaging: a potential new sign for characterization of liver lesions.
Mergo PJ; Helmberger T; Nicolas AI; Ros PR
AJR Am J Roentgenol; 1996 Feb; 166(2):379-84. PubMed ID: 8553952
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of liver hemangiomas on T1-weighted MR SE images by superparamagnetic iron oxide particles.
Grangier C; Tourniaire J; Mentha G; Schiau R; Howarth N; Chachuat A; Grossholz M; Terrier F
J Comput Assist Tomogr; 1994; 18(6):888-96. PubMed ID: 7962795
[TBL] [Abstract][Full Text] [Related]
11. [Superparamagnetic iron oxide particles: what value has the T1 effect in the MR diagnosis of focal liver lesions?].
Urhahn R; Adam G; Busch N; Chen JH; Euringer W; Günther RW
Rofo; 1996 Oct; 165(4):364-70. PubMed ID: 8963049
[TBL] [Abstract][Full Text] [Related]
12. [New MR contrast media in liver diagnosis. Initial clinical results with hepatobiliary Eovist (gadolinium-EOB-DTPA) and RES-specific Resovist (SH U 555 A)].
Reimer P; Tombach B; Daldrup H; Hesse T; Sander G; Balzer T; Shamsi K; Berns T; Rummeny EJ; Peters PE
Radiologe; 1996 Feb; 36(2):124-33. PubMed ID: 8867429
[TBL] [Abstract][Full Text] [Related]
13. [Superparamagnetic iron particles. The clinical results in the MR diagnosis of liver metastases].
Ham B; Reichel M; Vogl T; Taupitz M; Wolf KJ
Rofo; 1994 Jan; 160(1):52-8. PubMed ID: 8305693
[TBL] [Abstract][Full Text] [Related]
14. Use of a blood-pool contrast agent for MR-guided vascular procedures: feasibility of ultrasmall superparamagnetic iron oxide particles.
Wacker FK; Wendt M; Ebert W; Hillenbrandt C; Wolf KJ; Lewin JS
Acad Radiol; 2002 Nov; 9(11):1251-4. PubMed ID: 12449357
[TBL] [Abstract][Full Text] [Related]
15. MR imaging with i.v. superparamagnetic iron oxide: efficacy in the detection of focal hepatic lesions.
Winter TC; Freeny PC; Nghiem HV; Mack LA; Patten RM; Thomas CR; Elliott S
AJR Am J Roentgenol; 1993 Dec; 161(6):1191-8. PubMed ID: 8249724
[TBL] [Abstract][Full Text] [Related]
16. MR image-guided endovascular procedures with the ultrasmall superparamagnetic iron oxide SH U 555 C as an intravascular contrast agent: study in pigs.
Wacker FK; Reither K; Ebert W; Wendt M; Lewin JS; Wolf KJ
Radiology; 2003 Feb; 226(2):459-64. PubMed ID: 12563140
[TBL] [Abstract][Full Text] [Related]
17. [Dynamic MR imaging of liver lesions with superparamagnetic iron oxide (SH-U-555A)].
Saito K; Ishida J; Ito N; Kakizaki D; Kotake F; Abe K
Nihon Igaku Hoshasen Gakkai Zasshi; 2001 Feb; 61(3):84-8. PubMed ID: 11265126
[TBL] [Abstract][Full Text] [Related]
18. Hepatic MR imaging with ferumoxides: a multicenter clinical trial of the safety and efficacy in the detection of focal hepatic lesions.
Ros PR; Freeny PC; Harms SE; Seltzer SE; Davis PL; Chan TW; Stillman AE; Muroff LR; Runge VM; Nissenbaum MA
Radiology; 1995 Aug; 196(2):481-8. PubMed ID: 7617864
[TBL] [Abstract][Full Text] [Related]
19. Liver. II: Iron oxide-based reticuloendothelial contrast agents for MR imaging. Clinical review.
Petersein J; Saini S; Weissleder R
Magn Reson Imaging Clin N Am; 1996 Feb; 4(1):53-60. PubMed ID: 8673716
[TBL] [Abstract][Full Text] [Related]
20. Blood-pool MR contrast material for detection and characterization of focal hepatic lesions: initial clinical experience with ultrasmall superparamagnetic iron oxide (AMI-227).
Saini S; Edelman RR; Sharma P; Li W; Mayo-Smith W; Slater GJ; Eisenberg PJ; Hahn PF
AJR Am J Roentgenol; 1995 May; 164(5):1147-52. PubMed ID: 7717222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]